| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c69def3bf2d75c80ac422fcf66bf0e48 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0424
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00767
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00071 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-327
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B34-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0529 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-32 |
| filingDate |
2016-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8947cb65653fa9182edf8e2e1cbfb7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ebbb7dc851961f0ff0d96ad8c38c8b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39a62b78031999e1305a1c01e261a876
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be30b82c223ba3a5fc9c6de79fd04b29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd799b4a800a1ae73afc4728570d4a2a |
| publicationDate |
2018-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3313505-A1 |
| titleOfInvention |
Electroporation system for controlled localized therapeutics delivery |
| abstract |
Embodiments of the present invention provide an electroporation system comprising an electroporation probe having at least two contiguous electrodes configured to be inserted into biological tissue for electroporation treatment, and a pulse generator electrically connected to the probe and configured to drive the electroporation probe using a sequence of one or more electric pulses to cause current transmission through the probe and induce a non-uniform electric field in the biological tissue proximate the probe electrodes. Treatment tissue can be targeted by controlling the probe configuration, carrier solution characteristics and parameters of the electroporation pulse sequence to achieve predictable electroporation outcomes. This electroporation control method can also reduce potentially toxic effects of electroporation treatment. |
| priorityDate |
2015-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |